Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 7 Results

Title
Intervention Indication Therapeutic Area Year Actions
Diroximel fumarate for relapsing-remitting multiple sclerosis Diroximel fumarate (BIIB098; ALKS-8700) Multiple sclerosis (MS) Neurology 2019 View  |  Download
Fingolimod (Gilenya) oral formulation for multiple sclerosis in paediatric patients (aged 10 – 17 years) Fingolimod (Gilenya; FTY720; fingolimod hydrochloride) Multiple sclerosis (MS) Neurology 2017 View  |  Download
Glatiramer Acetate Depot for treating relapsing forms of multiple sclerosis in adults aged 18 to 55 years Glatiramer Acetate Depot (Copaxone) Multiple sclerosis (MS) Nephrology 2022 View  |  Download
Natalizumab (subcutaneous injection) for highly active relapsing remitting multiple sclerosis Natalizumab (BG00002; Tysabri; Antegren; AN-100226; ELND-002) Multiple sclerosis (MS) Neurology 2021 View  |  Download
Natalizumab biosimilar for treating relapsing-remitting multiple sclerosis Natalizumab (BG00002; Tysabri; Antegren; AN-100226; ELND-002) Multiple sclerosis (MS) Neurology 2022 View  |  Download
Ofatumumab for relapsing multiple sclerosis Ofatumumab (Arzerra) Multiple sclerosis (MS) Neurology 2019 View  |  Download
Ponesimod for Relapsing-remitting Multiple Sclerosis Ponesimod (ACT-128800; RG-3477) Multiple sclerosis (MS) Neurology 2017 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications